Why should the hameln pharma ltd product Glucose Intravenous Infusion BP 50% w/v not be administered with blood through the same infusion set?

The hameln pharma ltd product Glucose Intravenous Infusion BP 50% w/v should not be administered concomitantly with blood through the same infusion set because glucose solutions without electrolytes carry a risk of agglomeration.